CHMP - International Pharmaceutical Industry

News

CHMP recommend approval for Roche’s COVID-19 therapy

According to clinical data, Roche’s new COVID-19 treatment Actemra/RoActemra lowered mortality risk in critically ill adult patients. Roche has announced the Comm...

7 December 2021 News Actemra/RoActemra | CHMP

Continue Reading →

News

Vertex receives CHMP positive opinion for Kaftrio in children with cystic fibrosis

Vertex has announced that the EMA adopted a positive opinion for the label extension of Kaftrio®, in a combination regiment with ivacaftor, for the treatment of cyst...

17 November 2021 News children | CHMP

Continue Reading →

News

CHMP positive option for Pfizer-BioNTech COVID-19 vaccine in the EU

Pfizer and BioNTech have announced that the Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the administration of the Pfizer-...

6 October 2021 News BioNTech | booster shot

Continue Reading →

News

EMA fast-tracks Marinus Pharma’s rare epilepsy treatment

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has approved Marinus Pharmaceuticals’ request for accelerated assessment ...

1 September 2021 News CDD | CDKL5 deficiency disorder

Continue Reading →

News

CHMP recommends approval of Cablivi(TM) (caplacizumab)

First therapeutic to receive positive CHMP opinion for treatment of a rare blood disorder called acquired thrombotic thrombocytopenic purpura The European Me...

3 July 2018 News approval | blood

Continue Reading →